Revue Neurologique

Papers
(The TQCC of Revue Neurologique is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Pharmacological and non-pharmacological treatments for neuropathic pain: Systematic review and French recommendations188
Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians141
COVID-19 may induce Guillain–Barré syndrome131
Covid-19 and Guillain-Barré syndrome: More than a coincidence!90
First case of Covid-19 presented with cerebral venous thrombosis: A rare and dreaded case63
Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network63
Epidemiology of neurological diseases in older adults50
Parkinson's disease: From bench to bedside47
The effects of diet and sex in amyotrophic lateral sclerosis44
CGRP and migraine: from bench to bedside41
High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects41
Monoclonal antibodies blocking CGRP transmission: An update on their added value in migraine prevention39
Vitamin D serum levels in patients with migraine: A meta-analysis33
Acute meningoencephalitis in a patient with COVID-1933
Impact of disease-modifying treatments on humoral response after COVID-19 vaccination: A mirror of the response after SARS-CoV-2 infection30
Neurofeedback for cognitive enhancement and intervention and brain plasticity27
Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 2: Pharmacological treatment25
Etiological assessment of status epilepticus25
Melatonin (MEL) and its use in neurological diseases and insomnia: Recommendations of the French Medical and Research Sleep Society (SFRMS)24
Pregnancy with multiple sclerosis23
Syringomyelia and hydromyelia: Current understanding and neurosurgical management23
Clinical and genetic update of hereditary spastic paraparesis22
Migraine with aura21
French guidelines for neuropathic pain: An update and commentary21
Therapeutic news in ALS21
Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 3: Non-pharmacological treatment18
Risk factors of severe COVID-19 in people with multiple sclerosis : A systematic review and meta-analysis18
Pathophysiology of Parkinson's disease: Mitochondria, alpha-synuclein and much more…17
FUS mutation is probably the most common pathogenic gene for JALS, especially sporadic JALS17
Spinal cord stimulation for neuropathic pain17
Lafora disease: Current biology and therapeutic approaches16
Genetics of migraine16
Genetic/idiopathic generalized epilepsies: Not so good as that!16
From competition to cooperation: Visual neglect across the hemispheres16
Functional movement disorders16
Nonconvulsive status epilepticus in the elderly16
Spinal cord injury pain16
Stroke in women: When gender matters15
Primary Lateral Sclerosis: Clinical, radiological and molecular features15
The effects of Alzheimer's and Parkinson's disease on 28-day mortality of COVID-1915
Future prophylactic treatments in migraine: Beyond anti-CGRP monoclonal antibodies and gepants15
Intracerebral hemorrhage in CADASIL15
Brain plasticity and hearing disorders15
French validation of the Brief International Cognitive Assessment for Multiple Sclerosis14
What is the link between migraine and psychiatric disorders? From epidemiology to therapeutics14
No impact of confinement during COVID-19 pandemic on anxiety and depression in Parkinsonian patients14
Deep brain stimulation programming in Parkinson's disease: Introduction of current issues and perspectives14
MRI characteristics of MOG-Ab associated disease in adults: An update14
Association of obesity with recurrent stroke and cardiovascular events14
COVID-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies?14
Relationships between migraine and epilepsy: Pathophysiological mechanisms and clinical implications14
Intensive care unit-acquired weakness: Questions the clinician should ask13
The death of localizationism: The concepts of functional connectome and neuroplasticity deciphered by awake mapping, and their implications for best care of brain-damaged patients13
Infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society13
High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 2: putative scenarios and timeline in case of approval, recommendations for use, implementation, and ethical considerations in 13
Artificial intelligence and ChatGPT between worst enemy and best friend: The two faces of a revolution and its impact on science and medical schools13
Self-perceived attention difficulties are associated with sensory hypersensitivity in migraine13
Carotid webs associated with ischemic stroke. Updated general review and research directions13
Migraine in multiple sclerosis and other chronic inflammatory diseases13
Medical treatment of Rasmussen's Encephalitis: A systematic review12
Revised guidelines of the French Headache Society for the diagnosis and management of migraine in adults. Part 1: Diagnosis and assessment12
Imaging of the spine and spinal cord: An overview of magnetic resonance imaging (MRI) techniques12
Overview of the blood biomarkers in Alzheimer's disease: Promises and challenges12
Repair strategies for traumatic spinal cord injury, with special emphasis on novel biomaterial-based approaches12
Cortical excitability in migraine: Contributions of magnetic resonance imaging12
Chronic pain in Parkinson's disease: Clinical and pathophysiological aspects12
What are the infectious risks with disease-modifying drugs for multiple sclerosis and how to reduce them? A review of literature12
Functional Neurological Disorders in the medical education: An urgent need to fill the gaps11
Safety and effectiveness of levodopa-carbidopa intestinal gel for advanced Parkinson's disease: A large single-center study11
Validation in French of the Montreal Cognitive Assessment 5-Minute, a brief cognitive screening test for phone administration11
Area postrema syndrome as initial manifestation in neuromyelitis optica spectrum disorder patients: A retrospective study11
Will MRI replace the EEG for the diagnosis of nonconvulsive status epilepticus, especially focal?11
Correlation between blood glucose variability and the risk of death in patients with severe acute stroke11
Immunoglobulin shortage: Practice modifications and clinical outcomes in a reference centre11
Normal ageing of the brain: Histological and biological aspects11
Spinal cord injury: A multisystem physiological impairment/dysfunction11
Predictors of malignant middle cerebral artery infarction after mechanical thrombectomy10
A historical approach to hereditary spastic paraplegia10
The management of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage10
Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum10
Guillain-Barré syndrome following first injection of ChAdOx1 nCoV-19 vaccine: First report10
Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review10
Disease-modifying therapy usage in patients with multiple sclerosis in France: A 6-year population-based study10
Prevalence of stroke survivors in Parakou in northern Benin: A door-to-door community survey10
Interest of biological biomarkers in the diagnostic approach of neurocognitive disorders in the elderly9
Covid-19, the pandemic war: Implication for neurologists9
Steroid-responsive aseptic meningitis after BNT162b2 SARS-CoV-2 vaccine9
Urinary tract infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society9
Long-term outcomes after NeuroCOVID: A 6-month follow-up study on 60 patients9
Neuropathy of the elderly9
Genetic forms of frontotemporal lobar degeneration: Current diagnostic approach and new directions in therapeutic strategies9
Sensory neuronopathy as a major clinical feature of mitochondrial trifunctional protein deficiency in adults9
Phenotypic variability in amyotrophic lateral sclerosis9
A first case of Mild Encephalitis with Reversible Splenial Lesion(MERS) as a presenting feature of SARS-CoV-29
Serum cortisol levels in patients with a transient global amnesia8
Headache associated with refractive errors: Characteristics and risk factors8
Therapeutic news in Alzheimer's disease: Soon a disease-modifying therapy?8
Contribution of muscle MRI for diagnosis of myopathy8
Social cognition in epilepsy: State of the art and perspectives8
Influence of inflammatory status in the acute phase of stroke on post-stroke depression8
Clinical and biochemical markers in CIPN: A reappraisal8
Neurological adverse events of immune checkpoint inhibitors: An update of clinical presentations, diagnosis, and management8
Myasthenia gravis and pregnancy8
Acute telestroke in France: A systematic review8
Limb shaking transient ischemic attacks: A follow-up of 28 patients8
Prevalence of spasticity and spasticity-related pain among patients with Amyotrophic Lateral Sclerosis8
Therapeutic ultrasound: The future of epilepsy surgery?8
Melatonin (MEL) and its use in circadian rhythm sleep-wake disorders: Recommendations of the French Medical and Research Sleep Society (SFRMS)8
Immunomodulation in the acute phase of autoimmune encephalitis8
Visual and motor neglect: Clinical and neurocognitive aspects7
Cerebrospinal fluid biomarkers in SARS-CoV-2 patients with acute neurological syndromes7
Epilepsy and pregnancy: What should the neurologists do?7
Social and emotional cognition in patients with severe migraine consulting in a tertiary headache center: A preliminary study7
Prognostic value of spinal cord MRI in multiple sclerosis patients7
Neuro-ChatGPT? Potential threats and certain opportunities7
Clinical description of the broad range of neurological presentations of COVID-19: A retrospective case series7
Neuromyelitis optica spectrum disorders in South of Tunisia: A rare entity with low seroprevalence of anti-aquaporin 4 autoantibodies7
Management of intramedullary spinal cord tumors: A single-center experience of 247 patients7
Motor reserve: How to build neuronal resilience against ageing and neurodegeneration?7
Measles Sclerosing Subacute PanEncephalitis (SSPE), an intriguing and ever-present disease: Data, assumptions and new perspectives7
Genetics and familial distribution of multiple sclerosis: A review7
Comparisons of electrophysiological and clinical findings between young and elderly patients with Carpal Tunnel Syndrome7
Cognitive deficit, and neuropathological correlates, in the oldest-old7
Severe migraine and its control: A proposal for definitions and consequences for care7
Evaluation of hypersomnolence: From symptoms to diagnosis, a multidimensional approach7
Toward a coherent structuration of disorders of consciousness expertise at a country scale: A proposal for France7
EEG: Current relevance and promising quantitative analyses7
Effects of glutathione S-transferase M1 and T1 deletions on Parkinson's disease risk among a North African population7
Metabolic alterations in spinal and bulbar muscular atrophy7
Alexithymia in multiple sclerosis: Clinical and radiological correlations7
Epilepsy – from mysticism to science6
Challenges in diagnosis and management of adult spinal cord gliomas6
Prevalence and prospective evaluation of cognitive dysfunctions after SARS due to SARS-CoV-2 virus. The COgnitiVID study6
Overcoming the blood brain barrier in glioblastoma: Status and future perspective6
Negative motor networks: Electric cortical stimulation and diffusion tensor imaging6
Prevalence and characterisation of vocal fold motion impairment (VFMI) in patients with Multiple system atrophy compared with Parkinson's disease6
Othello syndrome in Parkinson's disease: A diagnostic emergency of an underestimated condition6
Arabic adaptation of the Edinburgh cognitive and behavioural Amyotrophic lateral sclerosis screen (ECAS-AR)6
Nusinersen treatment in adults with severe spinal muscular atrophy: A real-life retrospective observational cohort study6
Feasibility of changing for a rechargeable constant current neurostimulator in Parkinson's disease6
Interest of registries in neuropathic pain research6
Resistance exercise relieves symptoms of vestibular migraine patients with MRI diagnosis: A randomized parallel-controlled single-blind clinical trial6
The current international consensus criteria can lead to under and over-diagnosis of primary progressive aphasia variants6
Beyond the amyloid cascade: An update of Alzheimer's disease pathophysiology6
Endovascular therapy for acute ischemic stroke: The importance of blood pressure control, sedation modality and anti-thrombotic management to improve functional outcomes6
Narcolepsies, update in 20236
Degenerative cervical myelopathy6
Lennox-Gastaut syndrome: New treatments and treatments under investigation6
What contribution can genetics make to predict the risk of Alzheimer's disease?6
Post infectious encephalitis at Covid19: About one pediatric observation and review of the literature5
Brief International Cognitive Assessment for Multiple Sclerosis scores are associated with the cortical thickness of specific cortical areas in relapsing-remitting patients5
Recent advances in the diagnosis and the treatment of primary CNS lymphoma5
Health issues in polyhandicapped patients according to age: Results of a large French cross-sectional study5
Diaphragm ultrasound in the diagnosis of respiratory dysfunction in patients with amyotrophic lateral sclerosis5
Late-onset neutropenia after anti-CD20 therapy for multiple sclerosis, neuromyelitis optica spectrum disorders and MOG antibody-associated disease: A prospective study5
Low back pain in patients with multiple sclerosis: A systematic review and the prevalence in a French multiple sclerosis population5
An inventory of basic research in temporal lobe epilepsy5
Intracranial nociception5
Another extensive nitrous oxide (N2O) myelopathy: The wood for the trees?5
Botulinum toxin for benign essential blepharospasm: A systematic review and an algorithmic approach5
Intensive care management of patients with viral encephalitis5
How to treat neurogenic bladder and sexual dysfunction after spinal cord lesion5
Armand Trousseau (1801–1867), a neurologist before neurology5
Imaging of the aging brain and development of MRI signal abnormalities5
Strategy for genetic analysis in hereditary neuropathy5
Getting older with chronic temporal lobe epilepsy: What memory profile?5
Oral and intestinal dysbiosis in Parkinson's disease5
Sleep and armed conflict: future complications of war in Ukraine5
Medication overuse headache: Updating of the French recommendations regarding the treatment strategies5
The role of neuropsychological assessment in adults with attention deficit/hyperactivity disorders5
Wearable devices for seizure detection: Is it time to translate into our clinical practice?5
Cerebrovascular events during pregnancy and puerperium5
Clinical and pathophysiological implications of autoantibodies in autoimmune neuropathies5
Dyskinesia and hyperpyrexia syndrome: A case report and review of the literature5
Headaches during pregnancy5
Identification and measurement of cervical spinal cord atrophy in neuromyelitis optica spectrum disorders (NMOSD) and correlation with clinical characteristics and cervical spinal cord MRI data5
FOXP3 rs3761548 gene variant and interleukin-35 serum levels as biomarkers in patients with multiple sclerosis5
General anesthesia or conscious sedation for endovascular therapy of basilar artery occlusions: ETIS registry results5
The COVID-19 pandemic, an environmental neurology perspective5
The various forms of sensorimotor plasticity following limb amputation and their link with rehabilitation strategies4
Does post dural puncture headache exist in idiopathic intracranial hypertension? A pilot study4
Things you wanted to know (but might have been afraid to ask) about how and why to explore and modulate brain plasticity with non-invasive neurostimulation technologies4
The Marquise de Dampierre identified at last, the first described clinical case of Gilles de la Tourette syndrome4
Seizure incidence among neuromyelitis optica spectrum disorder patients4
Does ultrasound-guidance improve the outcome of botulinum toxin injections in cervical dystonia?4
Neuromuscular manifestations of lead poisoning in opium and herbal users in Iran4
Impulse control disorder-linked hypersexuality complicated by disseminated gonococcal infection in a patient with Parkinson's disease4
Mini review – The role of Glucocerebrosidase and Progranulin as possible targets in the treatment of Parkinson's disease4
Anatomical and neurophysiological basis of face recognition4
Development and initial validation of the polyhandicap severity scale4
Clinicoradiological and prognostic features of COVID-19-associated acute disseminated encephalomyelitis4
Neuropathy and pregnancy: An overview4
Electro-clinical presentation of hereditary transthyretin related amyloidosis when presenting as a polyneuropathy of unknown origin in northern France4
From the wax cast of brain ventricles (1508-9) by Leonardo da Vinci to air cast ventriculography (1918) by Walter E. Dandy4
Ten-year follow-up after mitoxantrone induction for early highly active relapsing-remitting multiple sclerosis: An observational study of 100 consecutive patients4
Neuro-Leptospirosis: Experience from a tertiary center of North India4
CSF biomarkers in primary CNS lymphoma4
Toxic-metabolic encephalopathy in adults: Critical discussion and pragmatical diagnostic approach4
Pregnancy and myopathies: Reciprocal impacts between pregnancy, delivery, and myopathies and their treatments. A clinical review4
Diagnostic and therapeutic approach to adult central nervous system vasculitis4
Spinal infarcts4
Sleep parameters associated with long-term outcome following subthalamic deep brain stimulation in Parkinson's disease4
Patients with Parkinson's disease and a history of falls have decreased cerebellar grey matter volumes in the cognitive cerebellum4
Treatment of hereditary amyotrophic lateral sclerosis4
Management of glioblastomas in the elderly population4
Changes in neuromuscular function in elders: Novel techniques for assessment of motor unit loss and motor unit remodeling with aging4
Iatrogenesis and neurological manifestations in the elderly4
Long-term cognitive outcomes in patient with epilepsy4
New onset refractory status epilepticus: State of the art4
Transcranial Doppler findings in a population with clinical probable reversible cerebral vasoconstriction syndrome4
Are there socio-economic inequities in access to reperfusion therapy: The stroke 69 cohort4
An update on epidemiology, diagnosis & management of NMO-SD in the tertiary neurology department of Marrakech (Morocco)4
Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma: What happened to the evidence?4
Clinical, electrophysiological and genetic characteristics of childhood hereditary polyneuropathies3
Acute stroke care in France: Survey in the 138 stroke units3
Retrospective evaluation of regional telemedicine team meetings for multiple sclerosis (MS) patients: Experience from the Caen MS expert center in Normandy, France3
Depression could modulate neuropsychological status in epilepsy3
Beyond uncal herniation: An updated diagnostic reappraisal of ipsilateral hemiparesis and the Kernohan-Woltman notch phenomenon3
Spinal cord tractopathy in paraneoplastic anti-CV2/CRMP5 myelitis responsive to plasma exchange3
Therapeutic tools for familial ALS3
Factors affecting the outcome of delayed intravenous thrombolysis (> 4.5 hours)3
Diagnostic and therapeutic issues of inflammatory diseases of the elderly3
COVID-19: A putative trigger for neuralgic amyotrophy3
Cerebral venous thrombosis in Behcet's disease. A report on 24 cases3
Awareness dimensions and associated factors in Alzheimer's disease3
Efficacy of microvascular decompression on the vascular compression type of neurogenic hypertension: A meta-analysis3
Psycho-sensory modalities of visual hallucinations and illusions in Parkinson's disease3
Acute and Post-Traumatic Stress Disorders: A biased nervous system3
Endogenous melatonin levels and therapeutic use of exogenous melatonin in tension type headache: A systematic review3
Non-infectious meningitis and CNS demyelinating diseases: A conceptual review3
Fluoxetine-induced chorea3
Tabes dorsalis in the 19th century. The golden age of progressive locomotor ataxia3
Contrast enhanced ultrasound of carotid plaque in acute ischemic stroke (CUSCAS study)3
Anglo-French neurological interactions in the 19th and early 20th centuries: Physicians, places and events3
An educational case series of Parkinson's disease during the COVID-19 pandemic3
A descriptive monocentric study in Algeria of adults with cerebral venous thrombosis3
How we sleep: From brain states to processes3
Autoimmune cerebellar hypermetabolism: Report of three cases and literature overview3
High glycemic variability: An underestimated determinant of stroke functional outcome following large vessel occlusion3
Early hyperdopaminergic state following sub-thalamic nucleus deep brain stimulation in Parkinson disease3
Intracerebral haemorrhage, microbleeds and antithrombotic drugs3
Weaning from mechanical ventilation in neurocritical care3
The new horizons for treatment of Late-Onset Pompe Disease (LOPD)3
Phenotype and management of neurologic intronic repeat disorders (NIRDs)3
Myelin oligodendrocyte glycoprotein associated disorder following SARS-CoV-2 vaccination3
Do disease-modifying drugs (DMD) have a positive impact on the occurrence of secondary progressive multiple sclerosis? Comment3
AD and its comorbidities: An obstacle to develop a clinically efficient treatment?3
Reversible parkinsonism and FTD due to spontaneous intracranial hypotension3
Spinal cord arterio-venous shunts: From classification to therapeutic management3
Insomnia in neurological disorders: Prevalence, mechanisms, impact and treatment approaches3
0.030301094055176